1
|
Zhao M: Lantibiotics as probes for
phosphatidylethanolamine. Amino Acids. 41:1071–1079. 2011.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Post JA, Bijvelt JJ and Verkleij AJ:
Phosphatidylethanolamine and sarcolemmal damage during ischemia or
metabolic inhibition of heart myocytes. Am J Physiol.
268:H773–H780. 1995.PubMed/NCBI
|
3
|
Zhao M, Li Z and Bugenhagen S:
99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding
molecular probe. J Nucl Med. 49:1345–1352. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Yao Y, Huang C, Li ZF, et al: Exogenous
phosphatidylethanolamine induces apoptosis of human hepatoma HepG2
cells via the bcl-2/Bax pathway. World J Gastroenterol.
15:1751–1758. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Keeble JA and Gilmore AP: Apoptosis
commitment-translating survival signals into decisions on
mitochondria. Cell Res. 17:976–984. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Itoh K, Hase H, Kojima H, Saotome K,
Nishioka K and Kobata T: Central role of mitochondria and p53 in
Fas-mediated apoptosis of rheumatoid synovial fibroblasts.
Rheumatology (Oxford). 43:277–285. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Suen DF, Norris KL and Youle RJ:
Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590.
2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Chipuk JE and Green DR: How do BCL-2
proteins induce mitochondrial outer membrane permeabilization?
Trends Cell Biol. 18:157–164. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Jiang L, Liu Y, Ma MM, Tang YB, Zhou JG
and Guan YY: Mitochondria dependent pathway is involved in the
protective effect of bestrophin-3 on hydrogen peroxide-induced
apoptosis in basilar artery smooth muscle cells. Apoptosis.
18:556–565. 2013. View Article : Google Scholar
|
11
|
Brunelle JK and Letai A: Control of
mitochondrial apoptosis by the Bcl-2 family. J Cell Sci.
122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Fan Y, Chen H, Qiao B, et al: Opposing
effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced
by dipyrithione. Mol Cells. 23:30–38. 2007.PubMed/NCBI
|
13
|
Hetman M, Kanning K, Cavanaugh JE and Xia
Z: Neuroprotection by brain-derived neurotrophic factor is mediated
by extracellular signal-regulated kinase and phosphatidylinositol
3-kinase. J Biol Chem. 274:22569–22580. 1999. View Article : Google Scholar : PubMed/NCBI
|
14
|
Tran SE, Holmstrom TH, Ahonen M, Kahari VM
and Eriksson JE: MAPK/ERK overrides the apoptotic signaling from
Fas, TNF, and TRAIL receptors. J Biol Chem. 276:16484–16490. 2001.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Boucher MJ, Morisset J, Vachon PH, Reed
JC, Lainé J and Rivard N: MEK/ERK signaling pathway regulates the
expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of
human pancreatic cancer cells. J Cell Biochem. 79:355–369. 2000.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Kovarik P, Mangold M, Ramsauer K, et al:
Specificity of signaling by STAT1 depends on SH2 and C-terminal
domains that regulate Ser727 phosphorylation, differentially
affecting specific target gene expression. EMBO J. 20:91–100. 2001.
View Article : Google Scholar
|
17
|
Battle TE and Frank DA: The role of STATs
in apoptosis. Curr Mol Med. 2:381–392. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wen Z, Zhong Z and Darnell JE Jr: Maximal
activation of transcription by Stat1 and Stat3 requires both
tyrosine and serine phosphorylation. Cell. 82:241–250. 1995.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Levy DE and Darnell JE Jr: Stats:
transcriptional control and biological impact. Nat Rev Mol Cell
Biol. 3:651–662. 2002. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Schindler C, Shuai K, Prezioso VR and
Darnell JE Jr: Pillars article: interferon-dependent tyrosine
phosphorylation of a latent cytoplasmic transcription factor.
Science. 257:809–813. 1992. View Article : Google Scholar
|
21
|
Townsend PA, Scarabelli TM, Davidson SM,
Knight RA, Latchman DS and Stephanou A: STAT-1 interacts with p53
to enhance DNA damage-induced apoptosis. J Biol Chem.
279:5811–5820. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Townsend PA, Cragg MS, Davidson SM, et al:
STAT-1 facilitates the ATM activated checkpoint pathway following
DNA damage. J Cell Sci. 118:1629–1639. 2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Stephanou A, Brar BK, Knight RA and
Latchman DS: Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and
Bcl-x promoters. Cell Death Differ. 7:329–330. 2000. View Article : Google Scholar : PubMed/NCBI
|
24
|
Pérez MJ and Cederbaum AI: Antioxidant and
pro-oxidant effects of a manganese porphyrin complex against
CYP2E1-dependent toxicity. Free Radic Biol Med. 33:111–127.
2002.PubMed/NCBI
|
25
|
Baracca A, Sgarbi G, Solaini G and Lenaz
G: Rhodamine 123 as a probe of mitochondrial membrane potential:
evaluation of proton flux through F(0) during ATP synthesis.
Biochim Biophys Acta. 1606:137–146. 2003. View Article : Google Scholar : PubMed/NCBI
|
26
|
Nera MS, Vanderbeek G, Johnson RO, Ruben
LN and Clothier RH: Phosphatidylserine expression on apoptotic
lymphocytes of Xenopus laevis, the South African clawed
toad, as a signal for macrophage recognition. Dev Comp Immunol.
24:641–652. 2000.PubMed/NCBI
|
27
|
Murphy KM, Ranganathan V, Farnsworth ML,
Kavallaris M and Lock RB: Bcl-2 inhibits Bax translocation from
cytosol to mitochondria during drug-induced apoptosis of human
tumor cells. Cell Death Differ. 7:102–111. 2000. View Article : Google Scholar : PubMed/NCBI
|
28
|
Johnson TL, Lai MB, Lai JC and Bhushan A:
Inhibition of cell proliferation and MAP kinase and akt pathways in
oral squamous cell carcinoma by genistein and biochanin A. Evid
Based Complement Alternat Med. 7:351–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Hellebrand EE and Varbiro G: Development
of mitochondrial permeability transition inhibitory agents: a novel
drug target. Drug Discov Ther. 4:54–61. 2010.PubMed/NCBI
|
30
|
Tomasello F, Messina A, Lartigue L, et al:
Outer membrane VDAC1 controls permeability transition of the inner
mitochondrial membrane in cellulo during stress-induced apoptosis.
Cell Res. 19:1363–1376. 2009. View Article : Google Scholar
|
31
|
Orrenius S: Mitochondrial regulation of
apoptotic cell death. Toxicol Lett. 149:19–23. 2004. View Article : Google Scholar : PubMed/NCBI
|
32
|
Ling YH, Lin R and Perez-Soler R:
Erlotinib induces mitochondrial-mediated apoptosis in human H3255
non-small-cell lung cancer cells with epidermal growth factor
receptorL858R mutation through mitochondrial oxidative
phosphorylation-dependent activation of BAX and BAK. Mol Pharmacol.
74:793–806. 2008. View Article : Google Scholar
|
33
|
Kirkin V, Joos S and Zörnig M: The role of
Bcl-2 family members in tumorigenesis. Biochim Biophys Acta.
1644:229–249. 2004. View Article : Google Scholar : PubMed/NCBI
|
34
|
Adams JM and Cory S: Life-or-death
decisions by the Bcl-2 protein family. Trends Biochem Sci.
26:61–66. 2001. View Article : Google Scholar : PubMed/NCBI
|
35
|
Newmeyer DD and Ferguson-Miller S:
Mitochondria: releasing power for life and unleashing the
machineries of death. Cell. 112:481–490. 2003. View Article : Google Scholar : PubMed/NCBI
|
36
|
Tsujimoto Y: Cell death regulation by the
Bcl-2 protein family in the mitochondria. J Cell Physiol.
195:158–167. 2003. View Article : Google Scholar : PubMed/NCBI
|
37
|
Baek D, Nam J, Koo YD, et al: Bax-induced
cell death of Arabidopsis is meditated through reactive
oxygen-dependent and -independent processes. Plant Mol Biol.
56:15–27. 2004. View Article : Google Scholar
|
38
|
Kondo K, Obitsu S, Ohta S, Matsunami K,
Otsuka H and Teshima R: Poly(ADP-ribose) polymerase
(PARP)-1-independent apoptosis-inducing factor (AIF) release and
cell death are induced by eleostearic acid and blocked by
alpha-tocopherol and MEK inhibition. J Biol Chem. 285:13079–13091.
2010. View Article : Google Scholar : PubMed/NCBI
|
39
|
Gogvadze V, Norberg E, Orrenius S and
Zhivotovsky B: Involvement of Ca2+and ROS in
alpha-tocopheryl succinate- induced mitochondrial permeabilization.
Int J Cancer. 127:1823–1832. 2010.
|
40
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
41
|
Kroemer G and Reed JC: Mitochondrial
control of cell death. Nat Med. 6:513–519. 2000. View Article : Google Scholar
|
42
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View Article : Google Scholar : PubMed/NCBI
|
43
|
Paris C, Bertoglio J and Bréard J:
Lysosomal and mitochondrial pathways in miltefosine-induced
apoptosis in U937 cells. Apoptosis. 12:1257–1267. 2007. View Article : Google Scholar : PubMed/NCBI
|
44
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
45
|
Wang X, Martindale JL and Holbrook NJ:
Requirement for ERK activation in cisplatin-induced apoptosis. J
Biol Chem. 275:39435–39443. 2000. View Article : Google Scholar
|
46
|
Bacus SS, Gudkov AV, Lowe M, et al:
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and
p38) and is independent of p53. Oncogene. 20:147–155. 2001.
View Article : Google Scholar : PubMed/NCBI
|
47
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
48
|
Tamura Y, Simizu S and Osada H: The
phosphorylation status and anti-apoptotic activity of Bcl-2 are
regulated by ERK and protein phosphatase 2A on the mitochondria.
FEBS Lett. 569:249–255. 2004. View Article : Google Scholar : PubMed/NCBI
|
49
|
Olson JM and Hallahan AR: p38 MAP kinase:
a convergence point in cancer therapy. Trends Mol Med. 10:125–129.
2004. View Article : Google Scholar : PubMed/NCBI
|
50
|
Dhanasekaran DN and Reddy EP: JNK
signaling in apoptosis. Oncogene. 27:6245–6251. 2008. View Article : Google Scholar
|
51
|
Yang J and Stark GR: Roles of
unphosphorylated STATs in signaling. Cell Res. 18:443–451. 2008.
View Article : Google Scholar : PubMed/NCBI
|
52
|
Lee HJ, Oh YK, Rhee M, et al: The role of
STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial
transmembrane potential during hepatic cell death induced by
LPS/d-GalN. J Mol Biol. 369:967–984. 2007. View Article : Google Scholar : PubMed/NCBI
|
53
|
Krasilnikov M, Ivanov VN, Dong J and Ronai
Z: ERK and PI3K negatively regulate STAT-transcriptional activities
in human melanoma cells: implications towards sensitization to
apoptosis. Oncogene. 22:4092–4101. 2003. View Article : Google Scholar
|
54
|
Xu B, Abdel-Fattah R, Yang L, Crenshaw SA,
Black MB and Hinton BT: Testicular lumicrine factors regulate ERK,
STAT, and NFKB pathways in the initial segment of the rat
epididymis to prevent apoptosis. Biol Reprod. 84:1282–1291. 2011.
View Article : Google Scholar : PubMed/NCBI
|